A detailed history of Janus Henderson Group PLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 50,810 shares of DVAX stock, worth $649,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,810
Previous 50,810 -0.0%
Holding current value
$649,859
Previous $570,000 0.7%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.73 - $12.58 $7,113 - $8,340
-663 Reduced 1.29%
50,810 $570,000
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $35 - $44
3 Added 0.01%
51,473 $638,000
Q4 2023

Feb 14, 2024

SELL
$13.09 - $14.98 $1,178 - $1,348
-90 Reduced 0.17%
51,470 $719,000
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $189 - $224
15 Added 0.03%
51,560 $761,000
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $620 - $829
-63 Reduced 0.12%
51,545 $665,000
Q1 2023

May 15, 2023

BUY
$9.44 - $11.88 $269,710 - $339,423
28,571 Added 124.02%
51,608 $506,000
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $20 - $26
-2 Reduced 0.01%
23,037 $245,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $29 - $52
3 Added 0.01%
23,039 $241,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $335 - $577
45 Added 0.2%
23,036 $290,000
Q1 2022

May 16, 2022

BUY
$9.75 - $14.44 $360 - $534
37 Added 0.16%
22,991 $250,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $151,942 - $241,584
11,537 Added 101.05%
22,954 $323,000
Q3 2021

Nov 16, 2021

BUY
$9.16 - $19.83 $104,579 - $226,399
11,417 New
11,417 $219,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.